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Abstract: As a hormone-sensitive condition with no single identifiable cause, breast cancer is a major 
health problem. It is characterized by a wide range of contributing factors and exposures occurring in 
different combinations and strengths across a lifetime that may be amplified during periods of 
enhanced developmental susceptibility and impacted by reproductive patterns and behaviours. The 
vast majority of cases are oestrogen-receptor positive and occur in women with no family history of 
the disease suggesting that modifiable risk factors are involved. A substantial body of evidence now 
links oestrogen-positive breast cancer with environmental exposures. Synthetic chemicals capable of 
oestrogen mimicry are characteristic of industrial development and have been individually and 
extensively assessed as risk factors for oestrogen-sensitive cancers. Existing breast cancer risk 
assessment tools do not take such factors into account. In the absence of consensus on causation and 
in order to better understand the problem of escalating incidence globally, an expanded, integrated 
approach broadening the inquiry into individual susceptibility breast cancer is proposed. Applying 
systems thinking to existing data on oestrogen-modulating environmental exposures and other 
oestrogenic factors characteristic of Westernisation and their interactions in the exposure, 
encompassing social, behavioural, environmental, hormonal and genetic factors, can assist in 
understanding cancer risks and the pursuit of prevention strategies. A new conceptual framework based 
on a broader understanding of the “system” that underlies the development of breast cancer over a 
period of many years, incorporating the factors known to contribute to breast cancer risk, could provide 
a new platform from which government and regulators can promulgate enhanced and more effective 
prevention strategies. 
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1. Introduction 
Cancer has been the focus of intensive research and discussion for over 50 years, during which 
97 
 
AIMS Environmental Science  Volume 3, Issue 1, 96-114. 
period age-standardised (AS) incidence rates of certain cancers, including breast cancer, have risen 
across the globe [1]. Of the c59 million deaths globally in 2008, 12–13% were from cancer, and it has 
been estimated that in the United States (US) up to 60% of those can be attributed to eight specific 
avoidable or modifiable factors; tobacco, alcohol, ionizing and solar radiations, occupations, infectious 
agents, obesity, and physical inactivity [2]. If this is the case then both the accurate prediction of risk 
and how to mitigate it in the interests of prevention, depend on a thorough understanding of risk factors 
not only individually but also in combination. 
There remains no consensus on how particular cancers start, although research has identified a 
number of plausible risk factors correlated to breast cancer, some of which are widely accepted. These 
are notably sex and age, age at first period, age at first birth, breast cancer in first-degree relatives, and 
ethnicity [3]. Other identified risks, both modifiable and non-modifiable, include use of HRT [4]; 
reproductive patterns of behaviour [4,5], alcohol consumption [6-8], height [9] circulating IGF-1 and 
prolactin levels [11,12], ionizing radiation [13,14], pre and post-menopausal weight-gain/obesity [15,16], 
dense breast tissue [17,18], dietary protein from red meat [19] and the presence of certain high-
penetrance genes (including BRCA1, BRCA2 and TP53), low-penetrance genes (such as the 
cytochrome P450 genes), DNA repair genes and genes encoding signaling molecules [20,21]. Major 
reviews conducted by independent groups have endorsed most as risk factors [22-24]. 
More recently an increasing number of environmental exposures have been the subject of research 
and intense debate amongst (inter alia) scientists, environmentalists, policy-makers and regulators. 
Women (and men) are exposed to many chemicals in the course of daily life. These range from 
preservatives in lipsticks to flame retardants in sofas, from plasticizers in water bottles to pesticides on 
fruits and vegetables. The vast majority have come into existence since the end of World War II, a 
period which has seen rapid and dramatic industrial development in many regions of the world [25-27]. 
It has been proposed by many, that such exposures, whether alone or in combination and/or at 
specific stages over a lifetime, trigger changes in DNA that lead via alterations in gene expression to 
the initiation of breast cancer. Epigenetics is the collective term applied to mechanisms that regulate 
gene expression but without altering the underlying DNA sequence [28,29]. A growing body of 
evidence now points to the role of such mechanisms (including the key processes of DNA methylation, 
histone modifications and post-transcriptional gene regulation by non-coding RNA) as being early 
events in the initiation of cancer [30-33]. It has been proposed that more than 300 genes and gene 
products undergo epigenetic alterations in some human cancers [34].  
Authoritative scientific reviews by bodies such as the Institute of Medicine (IOM), and 
Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERCC) are 
consistent in their observations that breast cancer is not one disease but a complex group of 
predominantly hormone-sensitive diseases occurring in an environmentally complex world where 
perturbations in hormone metabolism are increasingly common. Of these, oestrogen-positive (ER+) 
breast cancer is the largest group, accounting for more than 75% of all cases currently diagnosed in 
the US [1] and more than 80% in the UK [35]. In men, breast cancer is rare accounting for c1% of 
cases but 92% of which are classified ER+ [37,38] underlining the role of hormonal imbalance in the 
majority of breast cancers.  
With the exception only of skin cancer, breast cancer is now the most common form of cancer in 
women, and the International Agency for Research on Cancer (IARC) reports that incidence is 
increasing worldwide [38]. It has been proposed for some time that this increase in incidence cannot 
be explained simply by a growing and ageing population but that, given the preponderance of ER+ 
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cases, it reflects the growing number of environmental exposures that impact on the sensitive workings 
of oestrogen metabolism [39,40]. Evidence from experimental, ecological and epidemiological 
research collectively examined by expert committees have led to recommendations that the 
complexities of breast cancer causation should now be explored using a systems approach in which 
trans-disciplinary research should also be encouraged [23,24,41]. Sometimes referred to as “team 
science”, trans-disciplinary research is conducted by investigators from a number of disciplines, 
ranging from the genetic and molecular to the societal and regulatory, working together to devise new 
conceptual, theoretical and methodological innovations that move beyond discipline-specific 
approaches towards an integrated solution to a problem [42].  
The observation; “We are not students of some subject matter, but students of problems. And 
problems may cut across the borders of any subject matter or discipline.” [43] is exemplified in a 
recurring hypothesis for breast cancer causation. This proposes that particular characteristics of 
Westernisation in rapidly developing and newly industrialised countries are contributing to increased 
incidence in their female populations [44]. “Westernisation” is an umbrella term that attracts mixed 
and, in many parts of the world, unfavourable reactions. It leads in major changes in cultural 
behaviours that are protective of health whilst introducing the environmental agents and exposures 
instrumental to modernization and industrialization. Such agents include large numbers of endocrine 
disrupting chemicals (EDCs) which have been shown in multiple studies and confirmed in 
authoritative reviews, as being capable of modulating highly sensitive internal biochemical and 
hormonal processes [23,24,45].  
On-going research contributes greatly to our growing understanding of breast cancer at a 
molecular and cellular level and has led to the development of drugs including selective oestrogen-
receptor modulators as therapeutic and preventative agents. This approach which is reductionist in 
nature has given rise to a proliferation of specialisations, funding streams, research projects and 
reporting but which are, by their nature, geared neither to explaining the problem of increasing 
incidence worldwide nor promoting prevention. 
Molecular approaches towards understanding breast cancer whilst they have the capacity to 
identify preclinical biomarkers and therapeutic interventions to halt progression of the disease are not 
aimed specifically at prevention. The objective is, essentially, to cure a condition, not to prevent it from 
arising in the first place. Prevention in its most basic sense requires a different perspective. It has been 
proposed that developments in computer technology now provide a means of analysing large, disparate 
bodies of data using a non-linear, systems approach as a means of overcoming the limitations of the 
reductionist paradigm when it comes to human health and disease [46-49]. These developments provide 
the opportunity to consider increased incidence of breast cancer in a wider, environmental context.  
Whilst it is not the role of reductionism to address the multi-factorial origins of cancer, its findings 
can validate and inform systems biology and thereby the approach proposed here which would help 
establish whether cancer is what emerges when human interaction with the environment goes wrong. 
2. Breast cancer trends 
Global trends since 1973 show increased incidence rates of breast cancer in virtually all regions 
of the world [38]. The average annual rate of increase in 187 countries between 1980 and 2010 (30 
years) has been calculated as 3.1% [50] while incidence worldwide has increased by 20% since 2008. 
It is now the second most common cancer globally accounting for 12% of all new cancers and 25% of 
call cancers in women [51]. 
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In the UK, 33% of all new cancers are breast cancers and lifetime risk is currently one in eight [35]. 
In the US from 2001 to 2010 and notwithstanding a fall of 0.4% in AS and time-adjusted incidence 
rates in all cancers, breast cancer incidence neither increased nor decreased significantly [52,53]. 
However, data from the North American Association of Central Cancer Registries (NACCR), show 
that absolute numbers of breast cancers are currently on the increase [54].  
This increase has been argued as attributable to the combination of a growing and an ageing 
population coupled with more widespread screening [55]. However, accumulating evidence also points 
to environmentally driven epigenetic changes impacting on endocrine function as a further plausible 
explanation for the escalation in those breast cancers (the majority) exhibiting hormonal disruption [56]. 
Rising trends in obesity have been forecast to add significantly to incidence both in the UK and the 
US especially in post-menopausal women where obesity has been identified as an independent risk 
factor for ER+ breast cancer [57].   
Leaving aside “hereditary” cancers that constitute a distinct, but comparatively small, sub-group 
of breast cancers the vast majority of cases (>80%) do not display the inherited genetic component 
exemplified by mutations in the BRACA1, BRACA2 and TP50 genes [58]. It has been proposed that 
this large majority may reflect instead an accumulation of epigenetic mutations driven by exposures 
to EDCs [27,45,56,59,60] which amplify the risk of breast cancer via their modulating effects on 
oestrogen metabolism [61-63]. They may also reflect higher use in certain countries of HRT and oral 
contraception [40,58,64] illustrated by a decline of 8.8% in breast cancer incidence in the US in women 
aged 40–79 following widespread abandonment of HRT use between 2000 and 2005 [65]. 
Increases in incidence of breast cancer are not consistent across the globe [38]. The women of 
East Asia have, traditionally, experienced the lowest rates of breast cancer incidence in the world [62]. 
However, although rates of incidence are still lower in Asia than in the West, a significant rate of 
increase has been seen in this region over the past several decades. In Japan and Singapore rates have 
doubled, and in South Korea tripled, in the past 40 years while China’s urban registries have recorded 
increases in incidence of up to 30% in the decade to 2007 [66-68]. These rapid escalations in incidence 
require explanation and particularly those in South Korea where, in 2012, breast cancer incidence was 
the highest in Asia (overtaking Hong Kong), with an AS rate of 52.1 per 100,000 of population [69]. 
Also noteworthy is that the median age of breast cancer diagnosis in China has been reported as being 
nearly 10 years younger than in the either the US or Europe [70].  
3. Environmental chemical exposures 
It has been estimated that there are over 140,000 synthetic chemicals on the market worldwide 
today with another 1,000 or more being added every year [71]. Over 90% have not been tested for their 
effects on human health [72]. An estimated 85,000 synthetic chemicals are registered in the United 
States but with toxicological screening data available for only about 7% [73]. Various bodies, including 
the President’s Cancer Panel (PCP) [74], the IOM [75] and IBCERCC [24] have advocated further 
study of these environmental chemicals to better understand their potential to cause disease.  
The challenges for researchers in doing so are substantial. In some cases, while the impact of an 
environmental chemical on an adult may be known, its developmental effects on the foetus and in 
childhood may not be well documented (if at all), and measurable effects in adults may be a reflection 
of long-term cumulative exposure starting in utero [76,77]. This proposition was articulated by 
Heindle [78] as the “foetal basis of adult disease” which describes the interaction between the external 
environment and an individual’s genes as a determinant of health/disease in later life beginning in the 
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womb. As well as age at exposure, because some chemicals may be particularly harmful at specific 
stages of breast tissue development [43], other difficulties arise from duration of exposure and 
concentrations that can be hard to measure [79], possible effects of “mixing” where a chemical under 
review may, in combination with another, become toxic [80] and many EDCs exhibit J-type dose 
response curves [61].  
Immigration to an industrialised country, increases exposure to environmental pollutants [80-82] 
and breast cancer risk in later life may be higher in women whose mothers immigrate from un-
developed or developing countries to developed ones during pregnancy or when their daughters are 
children or adolescent [83]. Migration studies show that women who move from countries with low 
breast cancer incidence rates soon acquire any higher risk prevailing in the adopted country [84]. 
Women from Asian countries moving to the United States have been found to experience an 80% 
increase in risk after just one decade [85,86], a finding replicated in other studies [84,87], while age at 
immigration is a factor determining whether a woman carries the risk of her country of origin with her 
or acquires the risk of the country of destination [83].  
The proposition that environmental factors may be influencing breast cancer rates has been 
endorsed in studies of twins. One of the largest of these found that where one twin developed breast 
cancer the most significant contribution to her risk were the environmental exposures unique to her as 
opposed to her twin [88]. Inherited genes were found to contribute 27%, shared environmental factors 
6% and non-shared environmental factors 67%, of the risk. The study was subsequently re-analysed 
by others who concluded that “genetic susceptibility makes only a small to moderate contribution” to 
the incidence of breast cancer [89]. Further studies have since identified more genes that may increase 
breast cancer risk [90-92] but the most recent research suggests that it is epigenetic alterations that are 
the primary initiators of cancer development [93-98] and that these “epimutations” may be caused by 
environmental chemicals with endocrine disrupting potential [60,99]. 
3.1. Endocrine disrupting chemicals 
A large and growing number of studies focusing on endocrine disruption, and specifically 
oestrogen modulation, point to commonly encountered environmental chemicals as contributing to the 
increase of oestrogen-positive breast cancer incidence in post-menopausal women [100]. Such studies 
have been the subject of authoratative and detailed reviews [22,45,101]. 
An endocrine disrupting compound or chemical (EDC) is defined by the US Environmental 
Protection Agency (EPA) as “an exogenous agent that interferes with synthesis, secretion, transport, 
metabolism, binding action, or elimination of natural blood-borne hormones that are present in the 
body and are responsible for homeostasis, reproduction, and developmental process.” 
EDCs include oestrogen, rated by IARC as a Group One Carcinogen [102]. The 2009 Endocrine 
Society Scientific Statement cites a large body of evidence supporting the proposition that EDCs 
contribute to breast cancer risk via their effects on oestrogen metabolism [25]. 
Both the timing and duration of exposure to EDCs have been proposed as critical in terms of 
breast cancer incidence [24,101]. It has been observed that in the decades since World War II rates of 
breast cancer incidence have risen in parallel with the proliferation of synthetic chemicals some now 
identified as EDCs. A woman’s lifetime risk of breast cancer in the US in the 1940’s was 1 in 22. 
Today, the risk is 1 in 8 (12%) [1]. To what extent this increase is attributable to EDCs is the subject 
of intense debate. However, a woman’s risk aged 40 and over has been assessed as 2.5 fold higher in 
those exposed in utero to the synthetic oestrogen diethylstilbestrol (DES) than in women of the same 
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age who were not exposed, demonstrating the potential of intrauterine events to contribute to the 
development of cancer in later life [104-106].  
A survey in 2007 indicated that 216 chemicals had, by that date, been registered by international 
and national regulatory agencies as having been shown in at least one study to be implicated in 
mammary gland carcinogenesis [39]. Of those 216, 25 were from occupational exposures (in more 
than 5000 women), 10 had been registered with the US Food and Drug Administration (FDA) as food 
additives, and 73 either had been or were present in consumer products or as contaminants in food [45]. 
Although only six were directly identified as being EDCs, this class of chemicals have been shown not 
only to persist in the environment but, being fat-soluble, to accumulate in body fat including breast 
tissue (which is fatty) where they can remain for long periods [107,108].  
Breast tissue cells are considered to be at their most susceptible to the carcinogenic effects of 
EDCs starting in utero and continuing through puberty and adolescence up to the first full-term 
pregnancy [109]. A study that examined the effects of exposure shortly before birth to polycylic 
aromatic hydrocarbons (PAHs) from air pollution, vehicle exhaust, tobacco smoke and grilled foods 
showed altered oestrogen metabolism and an increased risk of breast cancer in the daughters of mothers 
exposed to higher levels in late pregnancy [110]. The effects of childhood and adolescent exposures to 
EDCs are difficult to assess but one study in 2007 showed that exposure in childhood or early 
adolescence to the then widely used but since banned pesticide DDT led to a five-fold increase in 
breast cancer before the age of fifty [111].  
Early, or “precocious” puberty has also been proposed as being a consequence of exposure in 
preceding years to EDCs [61,112] and which has been demonstrated in animal studies [76,113,114]. 
Biro and co-workers [115] noted significant increases in early puberty in girls in the US between the 
early 1990s and 2004–2006 (when their study was conducted) and which the authors propose may be 
linked to a general increase in BMI over the past 20 years, itself a possible consequence of exposures 
to environmental agents.  
Undisclosed chemicals represent another major potential source of human exposure to EDCs [116-118]. 
Fragranced consumer goods such as air fresheners, cleaning materials and personal care products 
(PCPs) contain ingredients that emit EDCs often as volatile organic compounds (VOCs). Despite the 
coming into force in the European Union in June 2007 of REACH (Registration, Evaluation, 
Authorisation and Restriction of Chemicals) neither this, nor legislation in the US require full 
disclosure of chemical ingredients in PCPs or other chemically-based consumer products where these 
are described and classified as a “fragrance” notwithstanding that VOCs emitted from such “fragrances” 
may be individually regulated as being toxic or hazardous [59,119].  
Assessing the risk posed by such EDCs even individually is complex and controversial. Large-
scale epidemiological studies of women with breast cancer exploring the effects of environmental 
chemicals in combination with other factors have produced contradictory results [120-122] serving to 
illustrate how complex some of the interactions may be and how difficult it is to assign or attribute risk 
between exposures and in proportion to one another. 
3.2. Impacts of EDCs on oestrogen metabolism 
Oestrogen is lipophilic and accumulates in fatty tissue [123]. Breast tissue is fatty and therefore 
a potential storage site both for endogenous oestrogen and for fat-soluble EDCs from the environment. 
Oestrogen metabolism is central to breast cancer, and elevated levels of oestrogen have been 
consistently associated with increased risk with numerous animal studies demonstrating that exposure 
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to environmentally encountered chemicals in general use in developed countries, such as bisphenol-A 
(BPA), produce measurable effects on oestrogen metabolism [124-126]. Oestrogen receptors (ERs) 
located in the nucleus of a cell bind with their designated endogenous ligands but can also bind with a 
range of exogenous synthetic compounds such as BPA which can then impact on cell signaling 
thorough a number of different pathways [127,128]. 
The potential for a biological effect is dependent upon the cell type, the concentration of the EDC 
in the target cell, and the binding affinity of that compound for an ER receptor [129]. Some EDCs exhibit 
relatively low binding affinities for the ER, suggesting that relatively high concentrations of the 
compounds are required to induce a response [130]. Studies suggest that EDCs may exert more potent 
effects during cell growth and particularly in utero when the foetus may be more sensitive to low 
concentrations of oestrogens [131]. Munoz-de-Toro and co-workers [113] argued that the primary target 
of bisphenol-A (BPA) is the foetal stroma, the only mammary tissue that expresses oestrogen receptors 
in utero and that BPA therefore alters stroma-epithelial interactions that mediate mammogenesis. In 
addition to this direct effect on mammary gland development, it is further postulated that BPA affects the 
hypothalamus and therefore the regulation of mammotrophic hormones at puberty, another critical 
window of susceptibility to endocrine disruption [132]. 
Studies in the 1960s and 1970s started to indentify the oestrogenicity of a number of industrial 
compounds and the pesticides o,p-DDT, kepone, methoxychlor, phenolic derivatives and 
polychlorinated biphenyls (PCBs). In the late 1990s, other environmental chemicals were added to the 
list including the pesticides toxaphene, dieldrin and endosulphan, several different compounds used in 
the food industry, antioxidants such a t-butylhydroxyanisole; plasticizers such as benzylbutylphthalate 
and 4-OH-alkylphenols along with substances used in dental restorations, such as BPA [133]. Later, 
complex mixtures of pollutants occurring in the environment such as diesel exhaust particles were also 
shown to have oestrogenic activity and were classified as EDCs [134].  
Multiple studies demonstrate the potential of synthetic oestrogens (such as BPA) from 
environmental exposures to lead to long-term health problems in wildlife where they have been shown 
to impact on fecundity and fertilisation rates [103,123,135-138]. Oestrogens are important regulators 
of the metabolic requirements for reproduction and have thereby been implicated in the aetiology inter 
alia of the feminization of fish and testicular dysgenesis including hypospadias, cryptorchidism [139,140] 
and testicular cancer [141]. In humans, exposure to animal oestrogens is primarily through diet with 
meat and dairy foods a principal source [142] and it has recently been reported that dietary oestrogens 
may increase ER+ breast cancer risk in post-menopausal women whose diets are higher in red meat 
and lower in whole grains and coffee [143]. 
Exogenous EDCs also include naturally occurring animal, phyto- and mycoestrogens that have 
the capacity to mimic endogenous oestrogen action and thereby affect hormone levels and/or bind to 
the ER [144]. Some have been shown to be hormonally active at extremely low concentrations, similar 
to endogenous hormones [145,146] and as being able to cross the placental barrier and enter foetal 
circulation [147-150]. It has also been demonstrated that those with smaller molecular structure are 
able to cross the blood-brain barrier which is still underdeveloped at birth [151]. 
4. Discussion 
Up until now, breast cancer has been approached on the basis that understanding it fully can be 
achieved by reducing it to manageable components and examining each of them in turn and in depth. 
Such methods have done much over the past decades to elucidate the processes involved in the 
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aetiology of the disease at both molecular and cellular level leading to improved treatment and, in 
consequence, falling mortality rates in most developed countries [38].  
Such progress notwithstanding, it cannot be said with certainty that exposure to any one of the 
established risk factors (or any combination thereof) “causes” breast cancer. This makes an effective 
strategy for primary prevention difficult both to design and to deliver. In the meantime, incidence 
continues to rise across the world. A different approach is required, one that is not in competition with 
the reductionist paradigm but supplemental to it. Systems thinking, which tackles issues that are 
embedded in complexity and especially those that involve human activity would be appropriate to the 
task because it addresses the interconnectedness that is usually absent in the reductionist approach. 
Many of the problems facing mankind comprise complex, dynamic systems consisting of multiple 
contributory factors that are both interdependent and self-organising and involve human interactions. 
A self-organising system has been defined as one “in which elements interact in order to achieve a 
global function or behaviour. This function or behaviour is not imposed by one or few elements, nor 
is it determined hierarchically. It is achieved dynamically as the elements interact with one another. 
These interactions produce feedbacks that regulate the system” [152]. In seeking to understand such 
problems, science has focused, historically, on understanding and testing individual components of the 
system rather than developing a more holistic and integrated understanding of “the problem” in its 
totality. As a consequence, one or more crucial aspects of the system (and particularly their interactions) 
may be excluded from the formulation of the “solution”. This means in turn that management of “the 
problem” is likely to be less effective as well as encouraging adoption and pursuit of a solution that 
may, in the absence of a full understanding of the underlying cause, create as many (or more) problems 
than it solves. A systems approach to problem solving focuses on “the problem” instead of “a solution” 
and looks at the interactions between its various components [153]. It involves a holistic, step-by-step 
process the aim of which is to understand the problem in its totality, proposing that the solution will 
emerge from a fuller understanding of the problem [154] but even where it does not, focus will usefully 
have been shifted to goals that can be achieved by regulation and policy making [155].  
The aetiology of cancer (as distinct from its biological hallmarks once developed) fits this 
description of a complex system well. Increased incidence of breast cancer (the problem) emerges 
from the self-organisation of external and internal factors interacting with one another (the system) 
giving rise to the behaviour (cancer). It has therefore been proposed that by looking for patterns within 
the exposome that reflect human homeostasis (i.e. the non-cancerous state) and identifying when and 
what changes or perturbations arise from environmental exposures, some consensus on causation of 
cancer may be achieved [28]. The exposome, a concept first proposed by Wild [156], represents “the 
totality of exposures received by a person during life, encompasses all sources of toxicants and, 
therefore, offers scientists an agnostic approach for investigating the environmental causes of chronic 
diseases.” [157]. This concept of the exposome is consistent with developments in epigenetic research 
which have shown that cancer is preceded by abnormalities arising from the epigenetic reprogramming 
of gene expression and specifically those “guardian” genes that have been found to be protective 
against cancer [158].  
Bearing in mind the probable number of environmental EDCs with potential specifically for 
oestrogenic activity, the biochemical complexities of oestrogen metabolism (including interactions 
with other agents) and oestrogen’s pivotal role in the development of ER+ breast cancer, research into 
the effects of individual EDCs on breast cancer risk needs to be complemented by a more multi-
connected, web-like conceptual framework in which to examine escalating incidence. Focused on 
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prevention, such an integrated, holistic approach would aim to synthesise knowledge of the molecular 
and biological processes involved in breast cancer with a growing parallel body of literature on 
environmental exposures that have been shown to modulate oestrogen metabolism. 
A number of models designed to calculate breast cancer risk have been developed over the past 
three decades. The Gail (1989) model (now incorporated in The Breast Cancer Risk Assessment Tool 
(BCRAT)) calculates, by reference to five largely non-genetic variables, the probability of developing 
breast cancer over a given lifespan. Later models include BRCAPR0 (after the BRCA1 and BRACA2 
genes) designed to assess probability of germline mutations in high-penetrance genes; the Claus risk 
tables [159] aimed at estimating risk of breast cancer in women with a first degree family history of 
ovarian cancer; the Tyrer-Cuzick model and the Breast and Ovarian Analysis of Disease Incidence and 
Carrier Estimation Algorithm (BOADCEA). Between them they incorporate some, but not all, 
established risk factors and the Claus model does not take into account any non-hereditary factors. 
Validation studies have produced mixed results [160,161]. 
What none of these models does, is to take into account potentially modifiable environmental 
exposures across a lifetime nor assess the potential for their interactions or cumulative effects in the 
development of breast cancer. A multi-level mathematical model of post-menopausal breast cancer 
causation addressing these and other factors, including social and behavioural, has been constructed 
by Hiatt and co-workers for the California Breast Cancer Research Programme (CBCRP) [162]. The 
model incorporates the strength of evidence for, and the relative strengths of associations arising out 
of the interactions between, risk factors in four designated and hierarchically constructed domains. 
What Hiatt’s model clearly demonstrates is the complex origins of cancer lending strength to the 
proposition that breast cancer is the result of interactions between numerous factors over a protracted 
period that in particular, but as yet unclear, combinations and levels of exposure lead from health to 
disease.  
Whilst aimed specifically at identifying risk of post-menopausal breast cancer in California in 
response to marked increases in incidence in the preceding years, the CBCRP model (or parts of it) 
could usefully be applied in the analysis of cancer scenarios in developing countries, particularly in 
East Asia, which have seen rapid increases in incidence over the past several decades.  
This study suggests that prevention of breast cancer depends not only on avoiding and reducing 
exposure to traditional risk factors but also on recognition and elimination of exposures to carcinogens 
especially oestrogens and other chemicals in the environment capable of upsetting finely tuned internal 
hormonal balance. This is made more difficult in developing countries with high rates of incidence 
where there are conflicting priorities between aspirations for economic development and prosperity on 
the one hand and concerns over environmental degradation and loss of cultural traditions beneficial to 
health on the other. Difficult though it may be to achieve, understanding and explaining the dramatic 
rise in incidence of breast cancer particularly in East Asia, requires assessment of the likely interactions 
between the established risk factors and the emerging risks posed by EDCs and other environmental 
exposures characteristic of inustrialsiation.  
Reducing exposure to such compounds will require a political and cultural shift so that protection 
of public health is regarded as paramount. This in turn will demand a comprehensive re-thinking and 
re-ordering of priorities by science, industry and government together with co-operation between 
independent organisations and institutions. All share a joint responsibility for delivering primary 
prevention which is first about identifying and then eliminating the causes of a disease before it affects 
people. Historically this has been based on a common sense approach together with recognition of 
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either proved or suspected causative agents. A new conceptual framework incorporating the factors 
known to contribute to breast cancer risk together with those known to confer protection from it, could 
provide a new platform from which government and regulators can promulgate enhanced and more 
effective prevention strategies based on a broader understanding of the “system” that is breast cancer. 
Systems thinking has evolved to understand the reality of how such interactions affect the whole (in 
this case increasing incidence) and is therefore consistent with the holistic approach to primary breast 
cancer prevention proposed here. 
5. Conclusion  
Current strategies to halt the rise in incidence of breast cancer worldwide have not been effective. 
In the European Union, where there are more than twice as many new breast cancers annually than in 
any other site; a woman is diagnosed with breast cancer every 2.5 minutes [38]. Major advances in 
cancer treatment have not been accompanied by similar achievements in reducing cancer incidence 
through increased prevention. Globally, rates rose by 20% between 1980 and 2010 and emerging 
evidence suggests that age of onset is falling. Incidence is projected to continue rising. At the same 
time, a growing number of compounds in the environment are being shown to have the capacity, 
whether individually or in combination, to interfere adversely with normal oestrogen metabolism. 
What is the connection? 
We may not be certain what causes breast cancer but there is a good body of evidence to show 
how risk can be mitigated. What is required is a way of linking that evidence to risk factors so as to 
identify the best protection “package” for women, deliverable via upstream changes in policy-making, 
aimed at creating a safer environment and better health culture. In setting about this daunting task it 
should be borne in mind that risk alone is not a cause of illness. Risk is the result of exposure to a 
hazard. If either hazard or exposure can be removed from the equation there is no risk. Avoiding hazard 
and reducing exposure are therefore key to decreasing risk and in this regulators and policy-makers 
will be key. 
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